This page is part of the FHIR Specification (v4.0.1: R4 - Mixed Normative and STU) in it's permanent home (it will always be available at this URL). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
Biomedical Research and Regulation Work Group | Maturity Level: 0 | Trial Use | Security Category: Anonymous | Compartments: Not linked to any defined compartments |
Detailed Descriptions for the elements in the MedicinalProductIndication resource.
| MedicinalProductIndication | |
| Element Id | MedicinalProductIndication |
| Definition | Indication for the Medicinal Product. |
| Cardinality | 0..* |
| Type | DomainResource |
| Summary | true |
| MedicinalProductIndication.subject | |
| Element Id | MedicinalProductIndication.subject |
| Definition | The medication for which this is an indication. |
| Cardinality | 0..* |
| Type | Reference(MedicinalProduct | Medication) |
| Summary | true |
| MedicinalProductIndication.diseaseSymptomProcedure | |
| Element Id | MedicinalProductIndication.diseaseSymptomProcedure |
| Definition | The disease, symptom or procedure that is the indication for treatment. |
| Cardinality | 0..1 |
| Type | CodeableConcept |
| Summary | true |
| MedicinalProductIndication.diseaseStatus | |
| Element Id | MedicinalProductIndication.diseaseStatus |
| Definition | The status of the disease or symptom for which the indication applies. |
| Cardinality | 0..1 |
| Type | CodeableConcept |
| Summary | true |
| MedicinalProductIndication.comorbidity | |
| Element Id | MedicinalProductIndication.comorbidity |
| Definition | Comorbidity (concurrent condition) or co-infection as part of the indication. |
| Cardinality | 0..* |
| Type | CodeableConcept |
| Summary | true |
| MedicinalProductIndication.intendedEffect | |
| Element Id | MedicinalProductIndication.intendedEffect |
| Definition | The intended effect, aim or strategy to be achieved by the indication. |
| Cardinality | 0..1 |
| Type | CodeableConcept |
| Summary | true |
| MedicinalProductIndication.duration | |
| Element Id | MedicinalProductIndication.duration |
| Definition | Timing or duration information as part of the indication. |
| Cardinality | 0..1 |
| Type | Quantity |
| Summary | true |
| MedicinalProductIndication.otherTherapy | |
| Element Id | MedicinalProductIndication.otherTherapy |
| Definition | Information about the use of the medicinal product in relation to other therapies described as part of the indication. |
| Cardinality | 0..* |
| Summary | true |
| MedicinalProductIndication.otherTherapy.therapyRelationshipType | |
| Element Id | MedicinalProductIndication.otherTherapy.therapyRelationshipType |
| Definition | The type of relationship between the medicinal product indication or contraindication and another therapy. |
| Cardinality | 1..1 |
| Type | CodeableConcept |
| Summary | true |
| MedicinalProductIndication.otherTherapy.medication[x] | |
| Element Id | MedicinalProductIndication.otherTherapy.medication[x] |
| Definition | Reference to a specific medication (active substance, medicinal product or class of products) as part of an indication or contraindication. |
| Cardinality | 1..1 |
| Type | CodeableConcept|Reference(MedicinalProduct | Medication | Substance | SubstanceSpecification) |
| [x] Note | See Choice of Data Types for further information about how to use [x] |
| Summary | true |
| MedicinalProductIndication.undesirableEffect | |
| Element Id | MedicinalProductIndication.undesirableEffect |
| Definition | Describe the undesirable effects of the medicinal product. |
| Cardinality | 0..* |
| Type | Reference(MedicinalProductUndesirableEffect) |
| Summary | true |
| MedicinalProductIndication.population | |
| Element Id | MedicinalProductIndication.population |
| Definition | The population group to which this applies. |
| Cardinality | 0..* |
| Type | Population |
| Summary | true |